SYNOVICS PHARMACEUTICALS, INC. SUBSCRIPTION AGREEMENTSubscription Agreement • January 29th, 2009 • Synovics Pharmaceuticals • Medicinal chemicals & botanical products • New York
Total Investment Amount: $_______________________________________ (includes $________ cash and $____ in principal amount of roll-over Bridge Notes subject to a Notice of Conversion of even date)
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 29th, 2009 • Synovics Pharmaceuticals • Medicinal chemicals & botanical products • New York
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of May 8, 2008, by and among Synovics Pharmaceuticals, Inc., a Nevada corporation (the “Company”), Axiom Capital Management, Inc. (the “Placement Agent”), and the purchasers of the Securities listed on Schedule A attached hereto (each an “Investor” or collectively, the “Investors”).
May 8, 2008Synovics Pharmaceuticals • January 29th, 2009 • Medicinal chemicals & botanical products
Reference is made to that certain agreement between Svizera Holdings BV (“Svizera”) and Synovics Pharmaceuticals, Inc. (“Synovics” or the “Company”) dated April 3, 2008 and amended April 24, 2008 (as so amended, the “Maneesh Side Letter”). Svizera and the Company hereby amend and supplement the Maneesh Side Letter as set forth below (and except as expressly amended and supplemented by this letter, the Maneesh Side Letter shall remain in full force and effect and unamended):
